Open access
Aug 2026
Disease-modifying anti-diabetic drugs (DMADDs): bridging the SIMPLE approach to disease interception
The traditional glucose-centric paradigm of type 2 diabetes management is being superseded by growing evidence that certain agents, sodium-glucose cotransporter-2 inhibitors (SGLT2i), glucagon-like peptide−1 receptor agonists (GLP-1RA), and pioglitazone, confer cardiovascular, renal, and hepatic benefits that extend we...
Nizameddin Koca, Seyit Uyar, Y. Şahintürk et al.
· Cardiovascular Diabetology · 0 citations